Browse Category

NYSE:AMRX News 8 January 2026

Amgen stock jumps on UBS buy call as Dark Blue deal sharpens focus on pipeline

Amgen stock jumps on UBS buy call as Dark Blue deal sharpens focus on pipeline

NEW YORK, January 7, 2026, 19:17 EST — After-hours Amgen shares (AMGN.O) rose 3.5% to $341.64 in Wednesday’s regular session and were last near that level after the bell. UBS assumed coverage with a buy rating and a $380 price target, saying it sees “upside from EPS and pipeline.” Why this matters now is simple: investors are testing whether Amgen’s…

Stock Market Today

  • FTAI Aviation Shares Surge Amid Valuation Concerns - Overvalued by 115%
    January 25, 2026, 11:36 AM EST. FTAI Aviation's share price closed at $292.10, soaring over 224% in the past year, prompting investors to scrutinize its valuation. Despite strong price gains, a Discounted Cash Flow (DCF) model estimates the stock's intrinsic value at $135.47, suggesting the shares are overvalued by 115.6%. The company reported a free cash flow loss of about $1.45 billion over the past twelve months, while analysts forecast positive cash flows up to 2029. FTAI's rich valuation raises questions amid a lack of new earnings guidance. Investors weigh the company's position in aviation assets against long-term sector demand. FTAI Aviation scores 0 out of 6 on valuation checks, signaling caution for those considering entry post recent gains.
Go toTop